Akash Kumar

Akash Kumar

Auto-generated profile, based on publicly available information

Akash Kumar

Department of Pediatrics Stanford School of Medicine Stanford California USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2022 in Nature Medicine
Verified
Journal Article
Open access
PDF file
AKAkash Kumar
Akash Kumar
KIKate Im
Kate Im
MBMilena Banjevic
Milena Banjevic
PNPauline C. Ng
Pauline C. Ng
TTTate Tunstall
Tate Tunstall
MRMatthew Rabinowitz
Matthew Rabinowitz
Preimplantation genetic testing (PGT) of in-vitro-fertilized embryos has been proposed as a method to reduce transmission of common disease; however, more comprehensive embryo genetic assessment, combining the effects of common variants and rare variants, remains unavailable. Here, we used a combination of molecular and statistical techniques to reliably infer inherited genome sequence in 110 embryos and model susceptibility across 12 common conditions. We observed a genotype accuracy of 99.0–99.4% at sites relevant to polygenic risk scoring in cases from day-5 embryo biopsies and 97.2–99.1% in cases from day-3 embryo biopsies. Combining rare variants with polygenic risk score (PRS) magnifies predicted differences across sibling embryos. For example, in a couple with a pathogenic BRCA1 variant, we predicted a 15-fold difference in odds ratio (OR) across siblings when combining versus a 4.5-fold or 3-fold difference with BRCA1 or PRS alone. Our findings may inform the discussion of utility and implementation of genome-based PGT in clinical practice.

28 March 2019 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
AKAkash Kumar
Akash Kumar
DZDiane B. Zastrow
Diane B. Zastrow
EKElijah J. Kravets
Elijah J. Kravets
DBDaniah Beleford
Daniah Beleford
MRMaura R. Z. Ruzhnikov
Maura R. Z. Ruzhnikov
JBJonathan A. Bernstein
Jonathan A. Bernstein

10 June 2023 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
SGStephanie U. Greer
Stephanie U. Greer
JBJacquelin Botello
Jacquelin Botello
DHDonna Hongo
Donna Hongo
BLBrynn Levy
Brynn Levy
PSPremal Shah
Premal Shah
AKAkash Kumar
Akash Kumar
Background: Diagnosis of rare genetic diseases can be a long, expensive and complex process, involving an array of tests in the hope of obtaining an actionable result. Long-read sequencing platforms offer the opportunity to make definitive molecular diagnoses using a single assay capable of detecting variants, characterizing methylation patterns, resolving complex rearrangements, and assigning findings to long-range haplotypes. Here, we demonstrate the clinical utility of Nanopore long-read sequencing by validating a confirmatory test for copy number variants (CNVs) in neurodevelopmental disorders and illustrate the broader applications of this platform to assess genomic features with significant clinical implications. Methods: We used adaptive sampling on the Oxford Nanopore platform to sequence 25 genomic DNA samples and 5 blood samples collected from patients with known or false-positive copy number changes originally detected using short-read sequencing. Across the 30 samples (a total of 50 with replicates), we assayed 35 known unique CNVs (a total of 55 with replicates) and one false-positive CNV, ranging in size from 40 kb to 155 Mb, and assessed the presence or absence of suspected CNVs using normalized read depth. Results: Across 50 samples (including replicates) sequenced on individual MinION flow cells, we achieved an average on-target mean depth of 9.5X and an average on-target read length of 4805 bp. Using a custom read depth-based analysis, we successfully confirmed the presence of all 55 known CNVs (including replicates) and the absence of one false-positive CNV. Using the same CNV-targeted data, we compared genotypes of single nucleotide variant loci to verify that no sample mix-ups occurred between assays. For one case, we also used methylation detection and phasing to investigate the parental origin of a 15q11.2-q13 duplication with implications for clinical prognosis. Conclusions: We present an assay that efficiently targets genomic regions to confirm clinically relevant CNVs with a concordance rate of 100%. Furthermore, we demonstrate how integration of genotype, methylation, and phasing data from the Nanopore sequencing platform can potentially simplify and shorten the diagnostic odyssey.

1 January 2017 in Informatics in Medicine Unlocked
Verified
Journal Article
Open access
AKAman Chandra Kaushik
Aman Chandra Kaushik
APAnirudh Pal
Anirudh Pal
AKAkash Kumar
Akash Kumar
Vivek Dhar DwivediVivek Dhar Dwivedi
Vivek Dhar Dwivedi
SBShiv Bharadwaj
Shiv Bharadwaj
SSShakti Sahi
Shakti Sahi
The nurseries and plantations of medicinally and economically important plants are facing challenge on health front as they are being rapidly exposed to fungal pathogens thereby affecting their health and productivity adversely. The plant pathogenic fungi significantly damage and reduce the flora of subcontinent. Lack of knowledge and trouble in identification of fungal pathogens, are imposing a peril to both the flora and human health all over the world. Albeit routine pathological techniques can be used for the identification of plant fungal pathogens but these methods are time consuming and often need sound knowledge in mycotaxonomy. Recently, molecular (DNA sequence) data has emerged with the nuclear ribosomal internal transcribed spacer (ITS) region (DNA barcoding) as crucial biomarker to disclose the necessary information for the taxonomic identification of plant pathogenic fungi. However, development of nucleotide sequence database of plant pathogenic fungi will enable authentic pathogen identification easy and quickly even by a person not trained in fungal taxonomy. This study presents the development of a new plant fungal pathogen -Internal Transcribed Spacer Sequence database (PFP- ITSS Database) holding 1215 ITS sequences collected from various sources. It represents 1215 plant fungal pathogens (PFP) in relation to their respective economical and medicinal plants; and is available at http://shaktisahislab.com/include/ITSdb. PFP-ITSS Database will provide useful information for better understanding of plant pathogenic fungi, which cause disease in both economical and medicinal plants. Keywords: ITS, Wrapper, Integrity, Mining, BLAST, Prime

28 October 2021 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
AKAkash Kumar
Akash Kumar
KIKate Im
Kate Im
MRMatthew Rabinowitz
Matthew Rabinowitz
Turley et al. (July 1 issue)1 state that MyOme “appears” to currently provide embryo selection using polygenic scores (ESPS) for nondisease traits. Although it may have appeared to be so, it is in fact not the case. Their statement was based on archived draft materials. We are conducting free-to-participant studies to assess the utility and tractability of ESPS. Although some participants have sought information on traits such as educational attainment, we determined that these issues distract from our health-focused conversation and mission. We generally agree with the recommendations of Turley et al. regarding messaging, augmented by an additional explanation of limitations. Nonetheless, feedback from our study has been positive; couples appreciate and feel empowered by the additional information, especially when the polygenic score modulates an increased family-history risk.

29 March 2025 in American Journal of Medical Genetics Part A
Verified
Journal Article
Open access
LDLiza Douiev
Liza Douiev
PAPaula Fernandez Alvarez
Paula Fernandez Alvarez
MFMarika Frank
Marika Frank
LHLucy Hanington
Lucy Hanington
THTrevor L. Hoffman
Trevor L. Hoffman
THTamar Harel
Tamar Harel
SIAH1 encodes for a RING‐type E3 ubiquitin ligase involved in protein ubiquitination. More specifically, it positively regulates Wnt signaling through promoting the accumulation of β‐catenin and mediates ubiquitination and degradation of Akt3 in neural development. Heterozygous de novo missense pathogenic variants in SIAH1 have been described in five unrelated individuals and are associated with developmental delay, hypotonia, and dysmorphic features. In this report, we present additional individuals from eight unrelated families and their clinical and genetic findings. We identified two missense and six predicted loss‐of‐function variants. Motor and speech delay and intellectual disabilities of varying severity were observed in all individuals. Neurodevelopmental issues, as well as infantile hypotonia and facial dysmorphism, were observed in the majority of individuals. Hearing loss, gastroesophageal reflux disease or other gastrointestinal issues, endocrinology abnormalities, and recurrent infections were observed in over 50% of individuals. This study expands the phenotypic spectrum of this syndrome and emphasizes the diverse impact of SIAH1 variation on multi‐system clinical manifestations.